Summary
We examined the effect of the angiotensin II receptor blocker, ZD 8731, on nerve function, capillary density, and blood flow in streptozotocin-diabetic rats. Deficits in sciatic motor and saphenous sensory nerve conduction velocity of 21% and 15%, respectively, were observed after 1 month of diabetes mellitus (p <0.001). These were completely ameliorated by a further month of ZD 8731 treatment (p <0.001). Treatment of non-diabetic rats for 1 month with ZD 8731 had no effect on motor or sensory conduction velocity. Sciatic nerve capillary density was not significantly affected by 1- or 2-month untreated diabetes, however, there was a 15% increase in density with ZD 8731 treatment (p <0.001). Treatment of non-diabetic rats for 1 month had no effect on capillary density. Diabetes prolonged the time taken for 80% conduction failure by 19% (p <0.05) and 49% (p <0.001) for 1 and 2 months of diabetes, respectively, when sciatic nerve was exposed to hypoxia in vitro. ZD 8731 treatment during the second month of diabetes limited the prolongation to 22%, not significantly different from 1 month of untreated diabetes but less than for the 2-month diabetic group (p <0.001). Concentrations of sciatic nerve polyol pathway metabolites were elevated six-fold and myo-inositol was reduced 40% by diabetes; ZD 8731 treatment was without effect. Acute experiments examined the effect of ZD 8731 on sciatic nerve blood flow using laser-Doppler flowmetry. In non-diabetic rats, blood flow changes followed the dose-dependent reductions in systemic arterial pressure and there were no significant variations in sciatic vascular resistance. In marked contrast, nerve blood flow was elevated by 47% (p <0.01), and vascular resistance decreased by 32% (p <0.01) in diabetic rats despite similar changes in blood pressure compared with the non-diabetic group. Thus, the investigation has identified abnormalities in vasa nervorum reactivity which are ameliorated by angiotensin II receptor blockade and may contribute to experimental diabetic neuropathy.
Article PDF
Similar content being viewed by others
References
Low PA, Tuck RR, Takeuchi M (1987) Nerve microenvironment in diabetic neuropathy. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D (eds) Diabetic neuropathy. Saunders, Philadelphia, pp 266–278
Tuck RR, Schmelzer JD, Low PA (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935–950
Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD (1986) Sural nerve oxygen tension in diabetes. BMJ 293: 1053–1054
Monafo WW, Eliasson SG, Shimazaki S, Sugimoto H (1987) Regional blood flow in resting and stimulated sciatic nerve of diabetic rats. Exp Neurol 99: 607–614
Cameron NE, Cotter MA, Low PA (1991) Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261: E1-E8
Yasuda H, Dyck J (1987) Abnormalities of endoneurial micro-vessels and sural nerve pathology in diabetic neuropathy. Neurology 37: 20–28
Tomlinson KC, Gardiner SM, Hebden A, Bennett T (1992) Functional consequences of streptozotocin-induced diabetes mellitus, with particular reference to the cardiovascular system. Pharmacol Rev 44: 103–150
Cameron NE, Cotter MA (1992) Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 35: 1011–1019
Tesfamariam B, Brown ML, Cohen RA (1992) Aldose reductase and myo-inositol in endothelial cell dysfunction caused by elevated glucose. J Pharmacol Exp Ther 263: 153–157
McVeigh GE, Brennan GM, Johnston GD et al. (1992) Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 771–776
Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA (1991) Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology and oxygen free radicals. Proc Natl Acad Sci USA 88: 6107–6111
Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87: 432–438
Cameron NE, Cotter MA, Dines KC, Love A (1992) Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35: 946–950
Cameron NE, Cotter MA, Robertson S (1991) Effects of essential fatty acid dietary supplementation on peripheral nerve and skeletal muscle function and capillarisation in streptozotoc-indiabetic rats. Diabetes 40: 532–539
Ward KK, Low PA, Schmelzer JD, Zochodne DW (1989) Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain 112: 197–208
Cameron NE, Cotter MA, Maxfield EK (1993) Antioxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36: 299–304
Bjork S, Aurell M (1990) Diabetes mellitus, the renin-angiotensin system, and angiotensin-converting enzyme inhibition. Nephron 55 [Suppl 1]: 10–20
Drury PL, Bodansky HJ, Oddie CJ, Cudworth AG, Edwards CRW (1982) Increased plasma renin activity in type one diabetes with microvascular disease. Clin Endocrinol 16: 453–461
Burden AC, Thursten H (1979) Plasma renin activity in diabetes mellitus. Clin Sci 56: 255–259
Sullivan PA, Gonggrijp H, Crowley MJ, Ferriss JB, O'Sullivan DJ (1980) Plasma angiotensin II and the control of diabetes mellitus. Clin Endocrinol 13: 387–392
O'Hare JA, Ferriss JB, Twomey BM, Gonggrijp H, O'Sullivan DJ (1982) Changes in blood pressure, body fluids, circulating angiotensin II and aldosterone, with improved diabetic control. Clin Sci 63: 415–418
Cameron NE, Cotter MA, Robertson S (1992) Angiotensin converting enzyme inhibition prevents the development of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia 35: 12–18
Sweet CS, Ulm EH (1988) Lisinopril. Cardiovasc Drug Rev 6: 181–191
Ferriere M, Bringer J, Richard JL, Rodier M, Jaffiol C, Mirouze J (1989) Effects of ACE-inhibition on glucose metabolism. Hormone Metab Res 22 [Suppl 1]: 65–69
Zaida AMAR, Hudliká O, Tyler KR, Wright AJA (1984) The effects of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle. Cardiovasc Res 18: 724–732
Hudlická O, Tyler KR (1986) Angiogenesis: the growth of the vascular system. Academic Press, New York
Oldham AA, Allott CP, Major JS, Pearce RJ, Roberts DA, Russell ST (1992) ICI D8731, a novel, potent and orally-effective angiotensin II antagonist. Br J Pharmacol 105 [Suppl]: 83 P (Abstract)
Allot CP, Oldham AA, Steel JA, Worrall V, Pearce RJ, Roberts DA, Russell ST (1992) Cardiovascular effects of the angiotensin II receptor antagonist ICI D8731 in the dog and marmoset. Br J Pharmacol 105 [Suppl]: 261 P (Abstract)
Cameron NE, Leonard MB, Ross IS, Whiting PH (1986) The effect of sorbinil on peripheral nerve conduction velocity, polyol concentrations and morphology in the streptozotocin-diabetic rat. Diabetologia 29: 168–174
Cameron NE, Cotter MA, Robertson S (1989) The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Q J Exp Physiol 74: 917–926
Stribling D, Mirrlees DJ, Harrison HE, Earl DCN (1985) Properties of ICI 128436, a novel aldose reductase inhibitor and its effects on diabetic complications in the rat. Metabolism 34: 336–344
Seneviratne KN, Peiris OA (1969) The effects of hypoxia on the excitability of the isolated peripheral nerves of alloxan-diabetic rats. J Neurol Neurosurg Psychiat 32: 462–469
Rundquist I, Smith QR, Michel ME, Ask P, Öberg PÅ, Rapaport SI (1985) Sciatic nerve blood flow measured by laser Doppler flowmetry and [14C]idoantipyrine. Am J Physiol 248: H311-H317
Scarphedisson JO, Hårding H, Thorén P (1988) Repeated measurements of cerebral blood flow in rats. Comparisons between the hydrogen clearance method and laser Doppler flowmetry. Acta Physiol Scand 134: 133–142
Low PA, Lagerlund TD, McManis PG (1989) Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int Rev Neurobiol 31: 355–438
Cameron NE, Cotter MA, Ferguson K, Robertson S, Radcliffe MA (1991) Effects of chronic α-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na+−K+-ATPase activity, and vascular supply in STZ-rats. Diabetes 40: 1652–1658
Cotter MA, Dines KC, Cameron NE (1993) Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analog iloprost. Naunyn Schmiedebergs Arch Pharmacol 347: 534–540
Robertson S, Cameron NE, Cotter MA (1992) The effect of the calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats. Diabetologia 35: 1113–1117
Low PA, Schmelzer JD, Ward KK, Yao JK (1986) Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am J Physiol 250: E94-E99
Smith WJ, Diemel LT, Leach RM, Tomlinson DR (1991) Central hypoxaemia in rats provokes neurological defects similar to those seen in diabetes mellitus: evidence for a partial role of endoneurial hypoxia in diabetic neuropathy. Neuroscience 45: 255–259
Masson EA, Church SE, Woodcock AA, Hanley SP, Boulton AJM (1988) Is resistance to ischaemic conduction failure induced by hypoxia? Diabetologia 31: 762–765
Malik RA, Masson EA, Sharma AK et al. (1990) Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia 33: 311–318
Young MJ, Veves A, Walker MG, Boulton AJM (1992) Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy? Diabetologia 35: 1146–1150
Tesfaye S, Harris N, Jacubowski J, Mody C, Ward J (1990) Impaired blood flow and arterio-venous shunting in human diabetic sural nerve. Diabetic Med 7 [Suppl 2]: 29 A (Abstract)
Tesfaye S, Harris ND, Wilson RM, Ward JD (1992) Exercise-induced conduction velocity increment: a marker of impaired peripheral nerve blood flow in diabetic neuropathy. Diabetologia 35: 155–159
Malik RA, Newrick PG, Sharma AK et al. (1989) Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 32: 92–102
Llewelyn JG, Thomas PK, Gilbey SG, Watkins PJ, Muddle JR (1988) Pattern of myelinated fibre loss in the sural nerve in neuropathy related to type 1 (insulin-dependent) diabetes. Diabetologia 31: 162–167
Wilkes BM (1987) Reduced glomerular angiotensin II receptor density in diabetes mellitus in rats: time course and mechanism. Endocrinology 120: 1291–1298
Ferris JB, Sullivan PA, Gonggrijp H, Cole M, O'Sullivan DJ (1982) Plasma angiotensin II and aldosterone in unselected diabetic patients. Clin Endocrinol 17: 261–269
Drury PL, Smith GM, Ferris JB (1984) Increased vasopressor responsiveness to angiotensin II in type 1 (insulin-dependent) diabeticpatients without complications. Diabetologia 27: 174–179
Connell JMC, Ding Y, Fisher BM, Frier BM, Semple PF (1986) Reduced number of angiotensin II receptors on platelets in insulin-dependent diabetes. Clin Sci 71: 217–220
Mann JFE, Murtz H, Sis J et al. (1988) Disordered angiotensin II receptor regulation in type 1 diabetes mellitus. Kidney Int 33: 302 (Abstract)
Hallab M, Bled F, Ebran JM, Suraniti S, Girault A, Fressinaud P, Marre M (1992) Elevated serum angiotensin I converting enzyme activity in type 1, insulin-dependent diabetic subjects with persistent microalbuminuria. Acta Diabetol 29: 82–85
Funakawa S, Okahara T, Imanishi M, Komori T (1983) Reninangiotensin system and prostacyclin biosynthesis in streptozotocin-diabetic rats. Eur J Pharmacol 94: 27–33
Hughes J, Roth RH (1971) Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol 41: 239–255
Cameron NE, Cotter MA, Robertson S, Maxfield EK (1993) Nerve function in experimental diabetes in rats: effects of electrical stimulation. Am J Physiol 264: E161-E166
Vane JR, Änggård EA, Botting RM (1990) Regulatory functions of the vascular endothelium. New Engl J Med 323: 27–36
Pohl U, Herlan K, Huang A, Bassenge E (1991) EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries. Am J Physiol 261: H2016-H2023
Cameron NE, Cotter MA, Dines KC, Maxfield EK (1993) Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 36: 516–522
Covell JW (1990) Neurohumoral control of the circulation. In: West JB (ed) Best and Taylor's physiological basis of medical practise, 12th edn. Williams and Wilkins, Baltimore, pp 276–290
Sundquist T, Öberg PÅ, Rapaport SI (1985) Blood flow in rat sciatic nerve during hypotension. Exp Neurol 90: 139–148
Rechthand E, Sato S, Oberg PA, Rapaport SI (1988) Sciatic nerve blood flow response to carbon dioxide. Brain Res 446: 61–66
Bell MA, Weddell AGM (1984) A descriptive study of the blood vessels of the sciatic nerve in the rat, man and other mammals. Brain 107: 871–898
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maxfield, E.K., Cameron, N.E., Cotter, M.A. et al. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic ratsand nerve function. Diabetologia 36, 1230–1237 (1993). https://doi.org/10.1007/BF00400799
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400799